Home

Abbott Laboratories (ABT)

123.67
+3.16 (2.62%)
NYSE · Last Trade: Jul 18th, 5:51 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
What's going on in today's session: S&P500 moverschartmill.com
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · July 18, 2025
Looking Into Abbott Laboratories's Recent Short Interestbenzinga.com
Via Benzinga · July 18, 2025
Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yieldmarketbeat.com
Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.
Via MarketBeat · July 18, 2025
Invesco, Vistra, Dell, Coinbase Trend In Midday Trade: S&P 500 Hits Record Highstocktwits.com
Via Stocktwits · July 18, 2025
P/E Ratio Insights for Abbott Laboratoriesbenzinga.com
Via Benzinga · July 17, 2025
These S&P500 stocks have an unusual volume in today's sessionchartmill.com
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Via Chartmill · July 18, 2025
Top S&P500 movers in Friday's sessionchartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · July 18, 2025
These Analysts Revise Their Forecasts On Abbott Following Q2 Resultsbenzinga.com
Via Benzinga · July 18, 2025
Microsoft To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga.com
Via Benzinga · July 18, 2025
ABT Q1 Deep Dive: Growth in Devices, Product Pipeline, and Tariff Mitigation Shape Outlook
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates.
Via StockStory · July 18, 2025
Abbott Reports 12% Growth in Device Salesfool.com
Via The Motley Fool · July 17, 2025
Top S&P500 movers in Thursday's sessionchartmill.com
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · July 17, 2025
Why Abbott Laboratories (ABT) Shares Are Plunging Today
Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but maintained its full-year guidance, which may have disappointed investors hoping for a raised outlook. 
Via StockStory · July 17, 2025
Abbott Reports 10.5% EPS Growth for Fiscal Q2fool.com
Via The Motley Fool · July 17, 2025
Unusual volume S&P500 stocks in Thursday's sessionchartmill.com
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via Chartmill · July 17, 2025
Nasdaq 100 Sets New Records, Small Caps Outperform: What's Moving Markets Thursday?benzinga.com
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor risk appetite.
Via Benzinga · July 17, 2025
Stay informed with the top movers within the S&P500 index on Thursday.chartmill.com
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Via Chartmill · July 17, 2025
Abbott (ABT) Q2 2025 Earnings Call Transcriptfool.com
Via The Motley Fool · July 17, 2025
Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investorsbenzinga.com
Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes and heart device sales.
Via Benzinga · July 17, 2025
Which S&P500 stocks are gapping on Thursday?chartmill.com
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via Chartmill · July 17, 2025
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hoursstocktwits.com
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said.
Via Stocktwits · July 17, 2025
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Missinvestors.com
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.
Via Investor's Business Daily · July 17, 2025
Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of $1.26 per share was in line with analysts’ consensus estimates.
Via StockStory · July 17, 2025
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 17, 2025
Wondering what's happening in today's S&P500 pre-market session?chartmill.com
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Via Chartmill · July 17, 2025